Cardiac positron emission tomography (PET) has emerged as a leading advanced imaging modality for the diagnosis and management of CS.

At present, the primary role of PET is to diagnose cardiac sarcoidosis but PET may potentially be used to identify multisystem disease. PET can provide clinicians with valuable information regarding prognosis of cardiac sarcoidosis. With more research, PET may be utilized to monitor therapy efficacy.

Nov 23, 2012 · Imaging abnormalities can commonly be seen on chest radiography, MDCT, 67 Ga scans, FDG PET, and PET/CT. FDG uptake from sarcoidosis is nonspecific and can mimic other disease processes, including lymphoma and diffuse metastatic disease.

From various studies, it has become clear that fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT aids in sarcoidosis care. In this article, an update on FDG PET/CT in sarcoidosis is provided.

Aug 17, 2018 · FDG PET/CT may be especially useful for assessing reversible granuloma, treatment response, disease extent, occult disease, and cardiac or osseous sarcoidosis, and determining the most suitable biopsy site.

PET/CT detection of both active inflammation and scar has diagnostic, prognostic, and therapeutic importance. Ongoing areas of research include the use of PET to quantify the extent of myocardial inflammation and the discrepancies in myocardial blood flow in the cardiac sarcoidosis population.

CT guided biopsy of the anterior mediastinal nodes revealed sarcoidosis. Sarcoidosis is characteristically FDG-avid, and PET-CT has been shown to have high sensitivity for thoracic disease. FDG-PET-CT may be useful for.

Apr 29, 2024 · 18F-FDG-PET – 18F-FDG-PET is sometimes helpful to identify occult lesions that are more accessible to biopsy than intrathoracic lesions; dedicated cardiac positron emission tomography (PET) scanning is also used in the evaluation of cardiac sarcoidosis .

Recent findings: PET has been shown to be a very sensitive technique for the assessment of inflammatory activity in sarcoidosis by detecting and quantifying the degree of inflammatory and granulomatous reactions that occur in the lungs and elsewhere in the body.

Imaging abnormalities can commonly be seen on chest radiography, MDCT, 67Ga scans, FDG PET, and PET/CT. FDG uptake from sarcoidosis is non-specific and can mimic other disease processes, including lym-phoma and diffuse metastatic disease.